We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
33 result(s) found, displaying 21 to 30
-
Designation or determinationOrphan drug
-
Designation or determinationOrphan drug
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SYLVANT siltuximab (rmc) 100mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SYLVANT siltuximab (rmc) 400mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SIGNIFOR LAR pasireotide 20 mg (as embonate) modified release powder for injection vial and 2 mL diluent in prefilled syringe composite pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SIGNIFOR LAR pasireotide 60 mg (as embonate) modified release powder for injection vial and 2 mL diluent in prefilled syringe composite pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SIGNIFOR LAR pasireotide 40 mg (as embonate) modified release powder for injection vial and 2 mL diluent in prefilled syringe composite pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Carbaglu carglumic acid 200 mg dispersible tablets tube.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SIGNIFOR pasireotide 900 microgram/1 mL (as diaspartate) solution for injection ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SIGNIFOR pasireotide 300 microgram/ 1 mL (as diaspartate) solution for injection ampoule.